Art

J-GLOBAL ID：200902223730228288   Reference number：07A1152123

Fibrate for treatment of primary biliary cirrhosis

原発性胆汁性肝硬変の治療薬としてのフィブレート系薬剤

Author (4)： IWASAKI Shinji (Kochi Medical School, Kochi, JPN) ,  AKISAWA Naoaki (Kochi Medical School, Kochi, JPN) ,  SAIBARA Toshiji (Kochi Medical School, Kochi, JPN) ,  ONISHI Saburo (Kochi Medical School, Kochi, JPN)
Material： Hepatology Research  (Hepatol Res)
Volume： 37  Issue： Supplement 3  Page： S515-S517  Publication year： Oct. 2007 
JST Material Number： W1284A  ISSN： 1386-6346  Document type： Article
Article type： 文献レビュー  Country of issue： Australia (AUS)  Language： ENGLISH (EN)

Thesaurus term： *primary biliary cirrhosis ,...
Semi thesaurus term： ホスファチジルコリンフリッパーゼ

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=07A1152123&from=J-GLOBAL&jstjournalNo=W1284A") }}

JST classification (2)： Clinical application of drugs acting on digestive system  (GW09020B) ,  Drug therapy(=pharmacotherapy)for digestive system diseases  (GH05020G)

Substance index (2)： Ursodeoxycholic Acid ,  Bezafibrate

Reference (5)：

• PAPATHEODORIDIS, GV. Ursodeoxycholic acid for primary biliary cirrhosis : final results of a 12-year, prospective, randomized, controlled trial. Am J Gastroenterol. 2002, 97, 2063-2070
• PARES, A. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid. Gastroenterol. 2006, 130, 715-720
• IWASAKI, S. Bezafibrate may have a beneficial effect in pre-cirrhotic primary biliary cirrhosis. Hepatol Res. 1999, 16, 12-18
• MIYAGUCHI, S. A novel treatment for refractory primary biliary cirrhosis?. Hepatogastroenterology. 2000, 47, 1518-1521
• ITAKURA, J. Prospective randomized crossover trial of combination therapy with bezafibrate and UDCA for primary biliary cirrhosis. Hepatol Res. 2004, 29, 216-222

Terms in the title (3)： 原発性胆汁性肝硬変 ,  治療薬 ,  フィブレート系薬剤